Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding. It will use the investment to further develop the capabilities of its powerful AI-augmented, knowledge discovery platform and to drive further commercial expansion across Europe and the US.  Environmental Technologies Fund (ETF) and a consortium of investors from across science, AI and analytics fields have provided this latest, strategically-important round of investment which will support Eagle Genomics’ high-growth ambitions.